Companies / Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc.

Nasdaq: CRBPCIK 1595097NORWOOD, MA

Financials · FY2022

Revenue$0
Net income$-78.54M
Total debt$0
Cash$23.37M
Diluted EPS$-5.90
Shares outstanding19.3M

Ownership

19.3M shares outstanding · as of Aug 4, 2026
2.1%Insiders
Ownership
Insiders2.13%411,880
10%+ / strategic11.77%2,276,750
Institutions65.25%12,620,949
Public float20.85%4,031,714

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Cohen YuvalCEOChief Executive Officer · Director
0.90%174,316
Moran Sean F.Chief Financial Officer
0.50%96,694
Smethurst DominicChief Medical Officer
0.46%89,790
Hodgson IanChief Operating Officer
0.26%51,080

Institutional holders 103

View all →
HolderValue% of shares
Cormorant Asset Management, LP$19.09M12.12%
Orbimed Advisors LLC$16.31M8.98%
BlackRock, Inc.$12.49M6.88%
Aberdeen Group plc$10.76M6.83%
Octagon Capital Advisors LP$7.77M4.94%
Vanguard Group Inc$7.00M4.44%
Citadel Advisors LLC$6.86M4.36%
Prosight Management, LP$5.57M3.54%
Armistice Capital, LLC$4.36M2.77%
Renaissance Technologies LLC$3.26M1.79%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 13, 2026Cohen Yuval
CEO
SellCommon Stock, par value $0.0001 per share$108.0K-14K
-7.37%
174,316
0.90% of shares
medium
Mar 2, 2026Smethurst Dominic
Executive
SellCommon Stock, par value $0.0001 per share$50.6K-6K
-6.36%
89,790
0.46% of shares
low
Feb 13, 2026Moran Sean F.
Executive
SellCommon Stock, par value $0.0001 per share$36.6K-5K
-4.64%
96,694
0.50% of shares
low
Feb 3, 2026Smethurst Dominic
Executive
SellCommon Stock, par value $0.0001 per share$26.6K-3K
-3.31%
95,887
0.50% of shares
low
Feb 3, 2026Hodgson Ian
Executive
SellCommon Stock, par value $0.0001 per share$19.5K-2K
-4.44%
51,927
0.27% of shares
low
Feb 17, 2026Hodgson Ian
Executive
SellCommon Stock, par value $0.0001 per share$6.3K-847
-1.63%
51,080
0.26% of shares
low
Jan 14, 2026Smethurst Dominic
Executive
GrantCommon Stock, par value $0.0001 per share$0+28K
+40.06%
99,172
0.51% of shares
low
Jan 14, 2026Cohen Yuval
CEO
GrantCommon Stock, par value $0.0001 per share$0+50K
+36.18%
188,187
0.97% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Octagon Capital Advisors LPPassive13G/A—955,000—
Aberdeen Group plcPassive13G—1,321,750—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CRBPCommon StockEquity21833P301BBG0078PJKQ7